Software Update for RAPIDPoint 500 Blood Gas System
Healthcare News | 2014-03-10
In January, field service engineers began implementing system upgrades at all RAPIDPoint® 500 Blood Gas System sites in conjunction with the commercial release of software version 2.2. Delivered at no charge to current customers, the enhanced system can help improve clinical decision making and better meet the information and connectivity needs of hospitals.
Equipped with v2.2 software, new and upgraded RAPIDPoint 500 Blood Gas Systems support ventilator settings, custom demographic fields, and multibyte characters. Connectivity capabilities have been expanded to support dual-port transmission and wireless roaming. The system can also support 100 sample-measurement cartridges to meet the needs of low-volume customers. Now with FDA approval, the RAPIDPoint 500 system extends pleural fluid pH testing to the U.S. market. A Russian-language user interface has also been introduced.
Ventilator settings: Record and track respiratory data for seven functions: flow, respiratory rate, continuous positive airway pressure, positive end expiratory pressure, peak inspiratory pressure, tidal volume, and Allen test. Custom demographics: Define up to 10 customizable fields to capture patient age, patient weight, draw location, insurance, or other specific information.
Enhanced language support: Along with the new Russian-language interface, the RAPIDPoint 500 system now supports multibyte characters in First and Last Name fields. This capability is a welcome addition in 13 languages: Chinese, English, Finnish, French, German, Italian, Japanese, Korean, Polish, Portuguese, Russian, Spanish, and Swedish.
New connectivity options: For customers who implement an external wireless bridge between the instrument and a data-management system, a new wireless roaming capability facilitates automatic reconnection to simplify workflow as the analyzer moves to different subnets in the hospital. In addition, the new software supports simultaneous dual-port transmission via the instrument’s Ethernet and serial ports.
In addition to the features outlined above, a change to the data entry process has also been made to help eliminate the chance of error. Users will now be required to select the intended patient from the patient list to prevent the inadvertent entry of the wrong patient ID on the demographic screen.
The American College of Chest Physicians recommends the use of blood-gas analyzers as the preferred pleural fluid chemistry test for categorizing and managing parapneumonic effusions.1 Offered widely since 2012, use of the RAPIDPoint 500 instrument to test pH levels of pleural fluid was approved by the FDA in 2013. This new capability has been bundled as part of the software release so that U.S. customers can now test the pH value of pleural fluid using this validated method.
International (English): +49 69 797 6602 You can call us Monday through Friday 8 am to 5 pm CET
Available for sale only in select countries.
Colic Gl, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline (AACP consensus statement). Chest. 2000;188:1158-1171.